Literature DB >> 20227468

Theacrine, a purine alkaloid with anti-inflammatory and analgesic activities.

Yuanyuan Wang1, Xiaorong Yang, Xinqiang Zheng, Jing Li, Chuangxing Ye, Xiaohong Song.   

Abstract

The anti-inflammatory and analgesic effects of theacrine (1, 3, 7, 9-tetramethyluric acid), a purine alkaloid which is abundantly present in Camellia kucha, were investigated. Xylene-induced ear edema, acetic acid-induced vascular permeability and lambda-carrageenan-induced paw edema were used to investigate anti-inflammatory activity, and acetic acid-induced writhing and hot-plate tests were used to determine analgesic effect. Oral administration of theacrine (8-32 mg/kg) induced dose-related anti-inflammatory and analgesic effects. On the other hand, oral caffeine administration (8-32 mg/kg) did not show an inhibitory effect on the inhibition of inflammatory response or cause analgesia. Additionally, the result of the acute toxicity test showed that the LD(50) of theacrine was 810.6 mg/kg (769.5-858.0mg/kg). The data obtained suggest theacrine possessed analgesic and anti-inflammatory activities. Crown Copyright (c) 2010. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227468     DOI: 10.1016/j.fitote.2010.03.008

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  9 in total

1.  Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans.

Authors:  Hui He; Dejian Ma; Laura Brooks Crone; Matthew Butawan; Bernd Meibohm; Richard J Bloomer; Charles R Yates
Journal:  J Caffeine Res       Date:  2017-09-01

2.  A 90-Day Oral Toxicological Evaluation of the Methylurate Purine Alkaloid Theacrine.

Authors:  Amy Clewell; Gábor Hirka; Róbert Glávits; Philip A Palmer; John R Endres; Timothy S Murbach; Tennille Marx; Ilona Pasics Szakonyiné
Journal:  J Toxicol       Date:  2016-08-22

Review 3.  Anti-inflammatory activity of alkaloids: an update from 2000 to 2010.

Authors:  Augusto Lopes Souto; Josean Fechine Tavares; Marcelo Sobral da Silva; Margareth de Fátima Formiga Melo Diniz; Petrônio Filgueiras de Athayde-Filho; José Maria Barbosa Filho
Journal:  Molecules       Date:  2011-10-11       Impact factor: 4.411

4.  Safety of Short-Term Supplementation with Methylliberine (Dynamine®) Alone and in Combination with TeaCrine® in Young Adults.

Authors:  Trisha A VanDusseldorp; Matthew T Stratton; Alyssa R Bailly; Alyssa J Holmes; Michaela G Alesi; Yuri Feito; Gerald T Mangine; Garrett M Hester; Tiffany A Esmat; Megan Barcala; Karleena R Tuggle; Michael Snyder; Andrew S Modjeski
Journal:  Nutrients       Date:  2020-02-28       Impact factor: 5.717

5.  Discriminant Analysis of Pu-Erh Tea of Different Raw Materials Based on Phytochemicals Using Chemometrics.

Authors:  Shao-Rong Zhang; Yu Shi; Jie-Lin Jiang; Li-Yong Luo; Liang Zeng
Journal:  Foods       Date:  2022-02-25

6.  Theacrine alleviates sepsis-induced acute kidney injury by repressing the activation of NLRP3/Caspase-1 inflammasome.

Authors:  Maoxian Yang; Peng Shen; Longsheng Xu; Min Kong; Congcong Yu; Yunchao Shi
Journal:  PeerJ       Date:  2022-10-04       Impact factor: 3.061

7.  Cognitive Performance and Mood Following Ingestion of a Theacrine-Containing Dietary Supplement, Caffeine, or Placebo by Young Men and Women.

Authors:  Daniel J Kuhman; Keanan J Joyner; Richard J Bloomer
Journal:  Nutrients       Date:  2015-11-19       Impact factor: 5.717

8.  Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use.

Authors:  Lem Taylor; Petey Mumford; Mike Roberts; Sara Hayward; Jacy Mullins; Stacie Urbina; Colin Wilborn
Journal:  J Int Soc Sports Nutr       Date:  2016-01-13       Impact factor: 5.150

9.  The effects of a caffeine-like supplement, TeaCrine®, on muscular strength, endurance and power performance in resistance-trained men.

Authors:  Kyle R Cesareo; Justin R Mason; Patrick G Saracino; Margaret C Morrissey; Michael J Ormsbee
Journal:  J Int Soc Sports Nutr       Date:  2019-10-28       Impact factor: 5.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.